Banco Bilbao Vizcaya Argentaria’s Bionano Genomics BNGO Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28	Closed	-$18.9K	–	707
2023 Q1	$18.9K	Hold	28	–	–	﹤0.01%	715
2022 Q4	$24.8K	Hold	28	–	–	﹤0.01%	711
2022 Q3	$31K	Hold	28	–	–	﹤0.01%	716
2022 Q2	$23K	Hold	28	–	–	﹤0.01%	693
2022 Q1	$47K	Hold	28	–	–	﹤0.01%	705
2021 Q4	$53K	Hold	28	–	–	﹤0.01%	774
2021 Q3	$94K	Hold	28	–	–	﹤0.01%	762
2021 Q2	$125K	Hold	28	–	–	﹤0.01%	762
2021 Q1	$137K	Buy	+28	New	+$158K	﹤0.01%	743

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's BNGO Position: Q2 2023 in Review

Banco Bilbao Vizcaya Argentaria sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 28 shares — an estimated $18.9K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in BNGO in Q1 2021 and held it in 9 quarters. The position peaked at $137K in Q1 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

Banco Bilbao Vizcaya Argentaria reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
Banco Bilbao Vizcaya Argentaria sold 28 Bionano Genomics shares in Q2 2023, an estimated $18.9K.
Banco Bilbao Vizcaya Argentaria first reported a position in Bionano Genomics in Q1 2021 and held it in 9 quarters.
Banco Bilbao Vizcaya Argentaria's Bionano Genomics position peaked at $137K in Q1 2021.
108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2023, filed 4 Aug 2023.